203 related articles for article (PubMed ID: 9749155)
1. [Brain mineralocorticoid receptor and blood pressure control in the conscious normotensive rat].
Rahmouni K; Barthelmebs M; Imbs JL; De Jong W
Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1009-12. PubMed ID: 9749155
[TBL] [Abstract][Full Text] [Related]
2. Brain mineralocorticoid receptor control of blood pressure and kidney function in normotensive rats.
Rahmouni K; Barthelmebs M; Grima M; Imbs JL; Wybren De Jong
Hypertension; 1999 May; 33(5):1201-6. PubMed ID: 10334812
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of testosterone production in rat Leydig cells by aldosterone is mineralocorticoid receptor mediated.
Ge RS; Dong Q; Sottas CM; Latif SA; Morris DJ; Hardy MP
Mol Cell Endocrinol; 2005 Nov; 243(1-2):35-42. PubMed ID: 16188378
[TBL] [Abstract][Full Text] [Related]
4. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
[TBL] [Abstract][Full Text] [Related]
5. Involvement of brain mineralocorticoid receptor in salt-enhanced hypertension in spontaneously hypertensive rats.
Rahmouni K; Barthelmebs M; Grima M; Imbs JL; De Jong W
Hypertension; 2001 Oct; 38(4):902-6. PubMed ID: 11641306
[TBL] [Abstract][Full Text] [Related]
6. Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression.
Cavallari LH; Fashingbauer LA; Camp JR; King ST; Geenen DL
J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):146-53. PubMed ID: 18957385
[TBL] [Abstract][Full Text] [Related]
7. Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?
Chai W; Garrelds IM; Arulmani U; Schoemaker RG; Lamers JM; Danser AH
Br J Pharmacol; 2005 Jul; 145(5):664-71. PubMed ID: 15834444
[TBL] [Abstract][Full Text] [Related]
8. Sex-specific effects of spironolactone on blood pressure in gonadectomized male and female Wistar rats.
Michaelis M; Hofmann PJ; Götz F; Bartel C; Kienitz T; Quinkler M
Horm Metab Res; 2012 Apr; 44(4):291-5. PubMed ID: 22266825
[TBL] [Abstract][Full Text] [Related]
9. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
10. Mineralocorticoid and glucocorticoid receptors in the amygdala regulate distinct responses to colorectal distension.
Venkova K; Foreman RD; Greenwood-Van Meerveld B
Neuropharmacology; 2009 Feb; 56(2):514-21. PubMed ID: 18977372
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system.
Savci V; Cavun S; Goktalay G; Ulus IH
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):388-98. PubMed ID: 12012025
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mineralocorticoid receptors with eplerenone alleviates short-term cyclosporin A nephrotoxicity in conscious rats.
Nielsen FT; Jensen BL; Marcussen N; Skøtt O; Bie P
Nephrol Dial Transplant; 2008 Sep; 23(9):2777-83. PubMed ID: 18424460
[TBL] [Abstract][Full Text] [Related]
13. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
van den Berg DT; de Kloet ER; van Dijken HH; de Jong W
Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978
[TBL] [Abstract][Full Text] [Related]
14. Central effects of mineralocorticoid antagonist RU-28318 on blood pressure of DOCA-salt hypertensive rats.
Van den Berg DT; de Kloet ER; de Jong W
Am J Physiol; 1994 Dec; 267(6 Pt 1):E927-33. PubMed ID: 7810636
[TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive rats.
Schupp N; Kolkhof P; Queisser N; Gärtner S; Schmid U; Kretschmer A; Hartmann E; Oli RG; Schäfer S; Stopper H
FASEB J; 2011 Mar; 25(3):968-78. PubMed ID: 21135038
[TBL] [Abstract][Full Text] [Related]
16. Different regulation of cardiac and renal corticosteroid receptors in aldosterone-salt treated rats: effect of hypertension and glucocorticoids.
Silvestre JS; Robert V; Escoubet B; Heymes C; Oubénaïssa A; Desopper C; Swynghedauw B; Delcayre C
J Mol Cell Cardiol; 2000 Jul; 32(7):1249-63. PubMed ID: 10860767
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.
Klanke B; Cordasic N; Hartner A; Schmieder RE; Veelken R; Hilgers KF
Nephrol Dial Transplant; 2008 Nov; 23(11):3456-63. PubMed ID: 18515791
[TBL] [Abstract][Full Text] [Related]
18. Influence of sodium intake on the cardiovascular and renal effects of brain mineralocorticoid receptor blockade in normotensive rats.
Rahmouni K; Barthelmebs M; Grima M; Imbs JL; De Jong W
J Hypertens; 2002 Sep; 20(9):1829-34. PubMed ID: 12195126
[TBL] [Abstract][Full Text] [Related]
19. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
20. Expression of mineralocorticoid receptors mRNA in the brain, heart and kidney of Sprague Dawley rats with renovascular hypertension.
Jackiewicz E; Szczepańska-Sadowska E; Maśliński W
Brain Res Bull; 2005 Feb; 65(1):23-9. PubMed ID: 15680542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
